MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
class a common stock,...
$77,476K
Proceeds from debt
issuance
$392K
Proceeds from the
exercise of stock options
$16K
Net cash provided by
financing activities
$77,441K
Canceled cashflow
$443K
Net increase
(decrease) in cash, cash...
$52,186K
Canceled cashflow
$25,255K
Repayment of notes payable
$392K
Taxes paid related to
net share...
$51K
Share-based compensation
expense
$3,775K
Accounts payable and
accrued expenses
$1,530K
Prepaid expenses
-$449K
Other assets
-$125K
Change in fair value of
warrants-Nonrelated Party
$109K
Change in fair value of
warrants-Related Party
$27K
Depreciation expense
$16K
Loss on disposal of
property and equipment
-$6K
Net cash used in
operating activities
-$25,255K
Canceled cashflow
$6,037K
Net loss before
noncontrolling interest
-$31,080K
Other liabilities
-$169K
Other current assets
$43K
Back
Back
Cash Flow
source: myfinsight.com
vTv Therapeutics Inc. (VTVT)
vTv Therapeutics Inc. (VTVT)